Pluripotent stem cells can differentiate into a variety of cell types during tissue development and regeneration. However, it is still unclear whether bone marrow-derived stem cells can migrate across the blood-brain barrier in many regions of the central nervous system (CNS) and if these cells can readily differentiate into functional parenchymal microglia. We thus studied the differentiation fate of bone marrow stem cells upon immigration into the CNS. To this end, we systemically transplanted stem cells that express green fluorescent protein (GFP) into lethally irradiated mice and found that these cells immigrated into the brain parenchyma of many regions of the CNS. Nearly all of the infiltrating cells had a highly ramified morphology and colocalized with the microglial marker iba1. Moreover, these cells expressed high levels of the protein CD11c, indicating that microglia of bone marrow origin may be potent antigen presenting cells. These data suggest that microglia of blood origin could activate cells of the adaptive immune system and cause harm to the CNS. Therefore, these results may have great clinical relevance for both immune-derived neuronal disorders and cancer patients undergoing allogeneic hematopoietic stem-cell transplantation.
t is a well-accepted fact that stem cells are capable of differentiating into multiple cell types (1) (2) (3) . In the central nervous system (CNS), however, neural stem cells have the ability to give rise to astrocytes and oligodendrocytes but not microglia (4, 5) . It has been suggested that microglia are replenished partly by division of resident cells and partly by immigration of circulating monocytes (6) , though evidence for the latter was based on many assumptions. Two previous studies have found many cells with microglial morphology associated with blood vessels and were thus identified as perivascular microglial cells. However, both papers reported that bone marrow-derived cells rarely crossed the blood-brain barrier (BBB) and transdifferentiated into parenchymal microglia (7, 8) . Moreover, this specific type of cell was only consistently observed in the cerebellum (8) . Therefore, the question still remains whether circulating stem cells can readily cross the BBB and differentiate into parenchymal microglia in other regions of the brain.
To test this hypothesis, we transplanted GFP-expressing bone marrow cells into lethally irradiated mice. We then evaluated the fate of the donor-derived cells in the CNS. Many of these cells were found in the parenchyma throughout multiple regions of the brain, and we show that the vast majority of these cells had differentiated into microglia since they were colabeled with the microglial marker iba1. Most importantly, these donor-derived microglial cells are likely to be effective antigen-presenting cells (APCs), because they contained high constitutive levels of the surface molecule CD11c. These data may be of great value for understanding the etiology of many neurodegenerative diseases and for cancer patients undergoing allogeneic hematopoietic stem-cell transplantation.
EXPERIMENTAL PROCEDURES

Animals
Adult male C57BL/6J mice (~25 g; Jackson Laboratory, Bar harbor, ME) were acclimated to standard laboratory conditions (14 h light, 10 h dark cycle; lights on at 0600 and off at 2000 h) with free access to rodent chow and water. Hemizygous transgenic mice expressing GFP under control of the chicken β-actin promoter and cytomegalovirus enhancer were initially obtained from the same vendor (Jackson Laboratory). A colony was then established and maintained in a C57BL/6J background. GFP mice were used as cell donors at 3-5 months of age. All protocols were conducted according to the Canadian Council on Animal Care guidelines, as administered by the Laval University Animal Welfare Committee.
Irradiation and bone marrow transplantation
Mice were exposed to 10 gray total-body irradiation using a cobalt-60 source (Theratron-780 model, MDS Nordion, Ottawa, ON, Canada). A few hours later, the animals were injected via a tail vein with ~5 x 10 6 bone marrow cells freshly collected from GFP mice. The cells were aseptically harvested by flushing femurs with Dulbecco's PBS containing 2% fetal bovine serum (DPBS-FBS). The samples were combined, centrifuged, and passed through a 25 gauge needle and then filtered through a 40 µm nylon mesh. Recovered cells were resuspended in DPBS-FBS at a concentration of 5 x 10 6 viable nucleated cells per 200 µl. Irradiated mice transplanted with this suspension were housed in autoclaved cages and treated with antibiotics (0.2 mg trimethorpine and 1 mg sulfamethoxazole/ml of drinking water given for 7 days before and 2 wk after irradiation).
Seven weeks after transplantation, the mice were deeply anesthetized via an intraperitoneal injection of a mixture of ketamine hydrochloride and xylazine and then were rapidly perfused transcardially with 0.9% saline containing 10 U/ml of heparin, followed by 4% paraformaldehyde in sodium phosphate buffer (pH 7.6 at 4°C). Brains were rapidly removed from the skulls, postfixed for 2 h, and then placed in a solution containing 20% sucrose diluted in 4% paraformaldehyde buffer overnight at 4°C. The frozen brains were mounted on a microtome (Reichert-Jung, Cambridge Instruments Company, Deerfield, IL), frozen with dry ice, and cut into 25 µm coronal sections from the olfactory bulb to the end of the medulla. The slices were collected in a cold cryoprotectant solution (0.05 M sodium phosphate buffer, pH 7.3, 30% ethylene glycol, 20% glycerol) and stored at -20°C.
Immunohistochemistry
Free-floating sections (25 µm thick) were incubated for 30 min in KPBS containing 4% goat serum, 1% BSA, and 0.4% Triton X-100. With the use of the same buffer solution, the sections were then incubated for 90 min in primary Ab (monoclonal rat anti-CD31, 1:1000, PharMingen, San Diego, CA; polyclonal rabbit anti-ionized calcium binding adaptor molecule 1 (iba1), 1:1000, provided by Dr. Y. Imai, National Institute of Neuroscience, Japan; polyclonal Armenian hamster anti-CD11c, 1:500, PharMingen) at room temperature. The sections were then rinsed 4 x 5 min in KPBS, followed by a 90 min incubation in fluorochrome-conjugated goat secondary Ab (anti-rat Rhodamine Red-X, 1:625, Jackson ImmunoResearch Laboratories, Inc., West Grove, PA; anti-rabbit Alexa 633, 1:625, Molecular Probes, Eugene, OR; anti-Armenian hamster Rhodamine Red-X, 1:1000). Sections were then rinsed 4 x 5 min in KPBS, mounted onto gelatin-coated slides and coverslipped with antifade medium composed of 96 mM Tris-Hcl, pH 8.0, 24% glycerol, 9.6% polyvinylalcohol, and 2.5% diazabicyclooctane (Sigma). Images were obtained using a Fluoview confocal microscope (FV-500, Olympus Optical) with x20 and x60 oil objectives. Confocal images were acquired by sequential scanning using a two-frame Kalman filter and a z-separation of 0.25 µm. The images were then processed to enhance contrast and sharpness using Adobe Photoshop 7 (Adobe Systems) and were assembled using Adobe Illustrator (Adobe Systems).
RESULTS
In this study, irradiated mice were transplanted with stem cells expressing GFP (9) . We then assessed the outcome of the donor-derived cells in the CNS of these lethally irradiated mice. We found that 7 wk after the bone marrow transplant, many GFP-expressing cells were present in various regions of the CNS, from the olfactory bulb to the end of the medulla (Fig. 1) . Moreover, most of the donor-derived cells were not associated with blood vessels, indicating that they had effectively crossed the BBB and infiltrated into the brain parenchyma. Regions that consistently showed a great number of infiltrating GFP-positive cells included the anterior olfactory nucleus; medial part (AOM; Fig. 1a and b) ; piriform cortex ( Fig. 1c and d) ; the lateral septal nucleus ( Fig.  1e and f) ; the hypothalamus ( Fig. 1g and h) ; the amygdaloid area ( Fig. 1i and j) ; the S1 layer of the cerebral cortex, trunk region (SiTr, Fig. 1k and l) ; the hippocampus ( Fig. 1m and n) ; the substantia nigra ( Fig. 1o and p) ; the midbrain ( Fig. 1q and r) ; the medulla ( Fig. 1s and t) ; the cerebellum ( Fig. 1u and v) ; and the area postrema ( Fig. 1w and x) . Though GFP-positive cells were also present in other regions of the CNS, they were fewer in number compared with the regions mentioned above (data not shown). Of interest is the fact that these cells were found across the whole rostro-caudal brain in both neurogenic and non-neurogenic areas, which indicates that bone marrow precursors have the ability to populate the cerebral tissue in a nonspecific manner.
We observed that nearly all of the GFP-positive cells had a highly ramified phenotype, resembling the morphology of parenchymal microglia. We thus assessed whether the ramified cells expressed the microglial marker iba1 (10) . As expected, all of the GFP-positive cells with a ramified morphology were immunoreactive to iba1, providing direct evidence that donor stem cells had differentiated into parenchymal microglia (Fig. 2) . In this regard, both GFP cells and endogenous microglial cells exhibited similar immunoreactive signal levels for iba1. We also tested the possibility that irradiation caused a massive neurodegeneration or death of other cell types in the brain, which could account for the high cellular immigration and transdifferentiation observed using our protocols. We thus used the fluorochrome Fluoro-Jade B (FJB), which is a sensitive and reliable marker for the histochemical localization of neuronal degeneration (11, 12) , and positive signals were not found in the brain of the animals included in this study (data not shown). Therefore, neurodegeneration may not account for the phenomenon presented in this study.
Macrophages are known to be very efficient APCs, and they express high levels of major histocompatibility complex type II (MHC-II), whereas brain microglia are poor APCs and have low surface levels of MHC-II. It has been shown that MHC-II expression is correlated with another membrane-bound protein known as CD11c (13) . Therefore, to determine if newly differentiated microglia of donor stem cell origin are good APCs, we assessed the expression levels of CD11c in tissues of the irradiated mice by immunohistochemistry (Fig. 3) . We found that all GFP-positive cells colocalized with CD11c staining, whereas virtually none of the residential microglia exhibited a positive signal for this protein. These data thus suggest that donor-derived microglia may be proficient APCs.
DISCUSSION
Taken together, our data clearly show that stem cells originating from the bone marrow have the capacity to migrate across the BBB and to transdifferentiate into microglia in vivo and that generation of these cells during adulthood does not solely depend on the proliferation of resident cells. To this date, evidence suggested that stem cells could not generate parenchymal microglia (4, 5), except for two papers showing that only a few infiltrating cells displayed this phenotype (7, 8) . One of these papers shows that this phenomenon seems to consistently occur only in the cerebellum (8) . This report showed that only very small amounts of bone marrow-derived cells (<0.3% of total donor-derived cells) had infiltrated past the BBB and differentiated into parenchymal microglia (8) . To the contrary, our data show that the large majority of GFP cells were clearly not associated with blood vessels, although a small percentage of cells derived from the donor had a perivascular nature. It is difficult to explain why bone marrow precursors were able to fully differentiate into parenchymal microglia throughout the cerebral tissue here, whereas previously analyzed mice exhibited only perivascular cells except for the cerebellum (8) . Mice of both studies were exposed to the same total radiation (10 gray), although it was delivered via different protocols. Indeed, the animals in the previous study were irradiated with two doses of 5 gray separated by a 3 h interval (8) for a total of 10 gray, whereas a single radiation session was administered to the animals of the present study.
The fact that we now demonstrate that hematopoietic cells are capable of infiltrating and generating microglia in various regions of the CNS has wide implications. Indeed, MHC-II is expressed only on the surface of activated APCs, such as macrophages, dendritic cells, and microglial cells in the brain. Expression of MHC-II is necessary for APCs to present a specific foreign antigen to T cells. Parenchymal microglial cells display the same characteristics as macrophages, but they are not recognized as being very potent APCs and their MHC-II levels are low compared with other APCs. It is also known that effective APCs express high CD11c levels, whereas parenchymal microglia contain very small quantities of this protein (13) . Our data show that microglia of bone-marrow stem cell origin express high levels of CD11c, which is a strong indication that these newly differentiated parenchymal microglia are likely to be effective APCs. This could have a critical impact on brain disorders that have an immune etiology, such as multiple sclerosis (MS). Indeed, macrophage-derived IL-12 stimulates the differentiation of a subset of T lymphocytes (CD4+) into T helper 1 cells (Th-1) that produce interferon gamma (IFNγ). These activated Th-1 cells are actually believed to play a critical role in MS, especially during the demyelinating episodes. Immigrating microglia from blood circulation may therefore contribute to the development of such immune processes in the cerebral environment.
Monocyte chemoattractant protein 1 (MCP-1) is likely to be essential in this recruitment of bone marrow-derived cells, because the release of this chemokine by endothelial cells is the key mechanism for the chemoattraction of cells of monocytic lineage. In this regard, MCP-1 and its receptor CCR2 have been implicated in a number of inflammatory diseases and the report that mice lacking CCR2 are resistant to experimental autoimmune encephalomyelitis (EAE), the animal model of MS, provided decisive evidence that this chemokine has a leading role in the cerebral infiltrating process (14) . This concept is further supported by the total absence of mononulear cell inflammatory infiltrates within the cerebral tissue of CCR2-deficient mice and immunized with the myelin oligodendrocyte glycoprotein peptide 35-55 (14) and the fact that monocyte recruitment to the CNS is a prerequisite step for the development of inflammatory lesions in EAE (15) . Differentiated macrophages into the brain parenchyma are believed to be directly responsible for the demyelination and axonal dysfunction, as a consequence of myelin sheath destruction by these activated phagocytes. The presence of these cells in the CNS of intact animals may play a critical role in the fate that the innate immune system may have on neurodegenerative disorders.
These data may also have a great clinical impact for cancer patients exposed to different levels of chemotherapy and radiotherapy, particularly for those undergoing allogeneic hematopoietic stem-cell transplantation. A similar immigration process of bone marrow precursors is expected to take place in the brain of these patients, but the physiological relevance of such a phenomenon has yet to be unraveled. Because these cells are more efficient APCs than endogenous microglia, it is tempting to propose that recruitment of bone marrow precursors may be a critical step in brain diseases with an immune etiology. A primary antibody directed against CD31 labeled with rhodamine red-X-conjugated secondary antibody was used to stain the endothelium of brain capillaries (red blood vessels). Several highly ramified GFP-positive cells were identified in various areas of the brain, namely anterior olfactory nucleus, medial part (AOM; a and b), piriform cortex (c and d), lateral septal nucleus (e and f), hypothalamus (g and h), amygdala (i and j), S1 cortex, trunk region (SiTr, k and l), hippocampus (m and n), substantia nigra (o and p), midbrain (q and r), medulla (s and t), cerebellum (u and v), and area postrema (w and x). Note that nearly all GFP-positive cells (green) in these regions had a ramified microglia-like morphology and most of these cells were not associated with blood vessels (red). Scale = 50 µm. a rhodamine red-X-conjugated secondary antibody (red blood vessels), whereas a primary antibody directed against iba1 was used to label microglia. They were then stained with an Alexa 633-conjugated secondary antibody (blue). Donor-derived cells (green) with a ramified morphology were always colocalized with iba1 staining (blue) and rarely colocalized with blood vessels (red). These results provide direct anatomical evidence that highly ramified cells are parenchymal microglia, which originate from circulating donor stem cells. Scale bar = 25 µm. Effective APCs express high levels of the surface molecule CD11c, which was visualized by immunohistochemistry using an anti-CD11c primary antibody and a rhodamine red-X-conjugated secondary antibody. Virtually all GFP-positive cells were immunoreactive to CD11c (red). Arrows indicate highly localized cellular expression of the surface antigen CD11c. These data suggest that infiltrating microglia derived from bone marrow precursors are immunologically competent to present antigens to cells of the adaptive immunity. Scale bar = 10 µm.
